Literature DB >> 9398839

Positional cloning of the APECED gene.

K Nagamine1, P Peterson, H S Scott, J Kudoh, S Minoshima, M Heino, K J Krohn, M D Lalioti, P E Mullis, S E Antonarakis, K Kawasaki, S Asakawa, F Ito, N Shimizu.   

Abstract

Autoimmune polyglandular syndrome type I (APS 1, also called APECED) is an autosomal-recessive disorder that maps to human chromosome 21q22.3 between markers D21S49 and D21S171 by linkage studies. We have isolated a novel gene from this region, AIRE (autoimmune regulator), which encodes a protein containing motifs suggestive of a transcription factor including two zinc-finger (PHD-finger) motifs, a proline-rich region and three LXXLL motifs. Two mutations, a C-->T substitution that changes the Arg 257 (CGA) to a stop codon (TGA) and an A-->G substitution that changes the Lys 83 (AAG) to a Glu codon (GAG), were found in this novel gene in Swiss and Finnish APECED patients. The Arg257stop (R257X) is the predominant mutation in Finnish APECED patients, accounting for 10/12 alleles studied. These results indicate that this gene is responsible for the pathogenesis of APECED. The identification of the gene defective in APECED should facilitate the genetic diagnosis and potential treatment of the disease and further enhance our general understanding of the mechanisms underlying autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9398839     DOI: 10.1038/ng1297-393

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  368 in total

1.  A cSNP map and database for human chromosome 21.

Authors:  S Deutsch; C Iseli; P Bucher; S E Antonarakis; H S Scott
Journal:  Genome Res       Date:  2001-02       Impact factor: 9.043

2.  Perfect conserved linkage across the entire mouse chromosome 10 region homologous to human chromosome 21.

Authors:  T Wiltshire; M Pletcher; S E Cole; M Villanueva; B Birren; J Lehoczky; K Dewar; R H Reeves
Journal:  Genome Res       Date:  1999-12       Impact factor: 9.043

Review 3.  Xenobiotic-metabolizing enzymes as autoantigens in human autoimmune disorders. An update.

Authors:  E Boitier; P Beaune
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

Review 4.  Autoimmune polyglandular syndrome type 1.

Authors:  P Obermayer-Straub; C P Strassburg; M P Manns
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

Review 5.  Autoimmunity in liver diseases.

Authors:  C P Strassburg; P Obermayer-Straub; M P Manns
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

Review 6.  Molecular aspects of primary immunodeficiencies: lessons from cytokine and other signaling pathways.

Authors:  Fabio Candotti; Luigi Notarangelo; Roberta Visconti; John O'Shea
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

Review 7.  The Finnish Disease Heritage III: the individual diseases.

Authors:  Reijo Norio
Journal:  Hum Genet       Date:  2003-03-08       Impact factor: 4.132

Review 8.  Human genetic susceptibility to Candida infections.

Authors:  Theo S Plantinga; Melissa D Johnson; William K Scott; Leo A B Joosten; Jos W M van der Meer; John R Perfect; Bart Jan Kullberg; Mihai G Netea
Journal:  Med Mycol       Date:  2012-06-04       Impact factor: 4.076

9.  New autoimmune genes and the pathogenesis of type 1 diabetes.

Authors:  Lars Hornum; Helle Markholst
Journal:  Curr Diab Rep       Date:  2004-04       Impact factor: 4.810

10.  LYN- and AIRE-mediated tolerance checkpoint defects synergize to trigger organ-specific autoimmunity.

Authors:  Irina Proekt; Corey N Miller; Marion Jeanne; Kayla J Fasano; James J Moon; Clifford A Lowell; Douglas B Gould; Mark S Anderson; Anthony L DeFranco
Journal:  J Clin Invest       Date:  2016-08-29       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.